EUCTR2008-006729-15-IT进行中（未招募）不适用
OPEN PILOT STUDY, TWO ARMS, WITH HISTORIC CONTROL, MULTICENTRIC TO EVALUATE SAFETY AND EFFICACY OF ASSOCIATION WITH EVEROLIMUS AND LOW DOSES OF CYCLOSPORIN AND STEROIDS AFTER INDUCTION WITH MONOCLONAL ANTIBODY ANTI CD25 IN PEDIATRIC PATIENTS AFTER KIDNEY TRANSPLANTS - ND
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age<18 years at time of screening
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Systemic infection before starting everolimus
研究者
相似试验
尚未招募
4 期
A clinical saftey and efficacy trial of Sugarlite a marketeted product on Healthy lifestyle modificatioCTRI/2021/02/030921Zydus Wellness
尚未招募
Unknown
To Investigate the change in oral bioavailability of Nicotinamide Mononucleotide (NMN, 500mg) when 5mg Bioperine is added to NMN 500mg in normal healthy volunteers.CTRI/2023/11/059982Sami-Sabinsa Group Limited
尚未招募
4 期
A study to check reduction in blood glucose level over 24 hours after consuming anti-diabetic medicines- Lobeglitazone or Pioglitazone using Continuous Glucose Monitoring device.CTRI/2023/03/050577Dr Suhas Erande
尚未招募
2 期
A CLINICAL TRIAL TO STUDY THE EFFECT OF PATHADI CHURNA IN FUNGAL INFECTION OF SKICTRI/2021/01/030238Dean Faculty of Ayurved Parul University
进行中（未招募）
不适用
A PILOT, RANDOMIZED, SINGLE SITE, 3 PARALLEL ARMS, OPEN-LABEL STUDY IN PATIENTS ON CHRONIC DIALYSIS WITH END STAGE RENAL DISEASE (ESRD) TO EVALUATE THE ENHANCING EFFECT OF TWO DOSES OF THYMOSIN ALPHA 1 ON THE IMMUNOGENICITY OF EGG-DERIVED H1N1sw MONOVALENT INFLUENZA VACCINE - NDZADAXIN ENHANCING EFFECT IN PATIENTS ON CHRONIC DIALYSIS WITH END STAGE RENAL DISEASE (ESRD) TREATED WITH EGG-DERIVED H1N1sw MONOVALENT INFLUENZA VACCINEMedDRA version: 12.1Level: LLTClassification code 10014647Term: End stage renal failureEUCTR2009-016362-85-ITSIGMA-TA